| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
66,433 |
53,930 |
$3.94M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
9,270 |
7,948 |
$900K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,992 |
8,396 |
$881K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
6,889 |
6,423 |
$737K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,579 |
3,417 |
$381K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
14,671 |
13,675 |
$250K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
6,505 |
5,913 |
$180K |
| 99460 |
|
2,105 |
1,892 |
$166K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
8,731 |
7,961 |
$159K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
16,122 |
14,726 |
$145K |
| 94060 |
|
2,936 |
2,667 |
$106K |
| 90461 |
|
6,533 |
6,065 |
$94K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
704 |
692 |
$85K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,747 |
2,523 |
$52K |
| 99462 |
|
2,652 |
1,788 |
$48K |
| 99223 |
Prolong inpt eval add15 m |
167 |
161 |
$39K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
11,030 |
10,151 |
$32K |
| 99188 |
|
2,052 |
1,928 |
$20K |
| 87807 |
|
2,669 |
2,461 |
$19K |
| 92552 |
|
5,380 |
5,105 |
$19K |
| 92558 |
|
2,137 |
2,067 |
$16K |
| 99051 |
|
1,877 |
1,745 |
$9K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,242 |
2,021 |
$8K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
287 |
278 |
$8K |
| 90686 |
|
2,284 |
2,213 |
$7K |
| H0049 |
Alcohol and/or drug screening |
737 |
716 |
$6K |
| 90670 |
|
4,126 |
3,902 |
$6K |
| 99381 |
|
76 |
63 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
260 |
248 |
$4K |
| 69210 |
|
124 |
94 |
$3K |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
2,229 |
1,995 |
$3K |
| 31000 |
|
109 |
99 |
$3K |
| 81002 |
|
1,508 |
1,324 |
$3K |
| 88720 |
|
1,345 |
1,066 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
285 |
185 |
$1K |
| 99233 |
Prolong inpt eval add15 m |
21 |
14 |
$1K |
| 90744 |
|
2,509 |
2,405 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
22 |
18 |
$638.27 |
| 92587 |
|
49 |
37 |
$565.76 |
| 90698 |
|
3,199 |
3,072 |
$439.94 |
| 90677 |
|
426 |
420 |
$410.00 |
| 97803 |
|
110 |
110 |
$397.46 |
| 83655 |
|
715 |
694 |
$390.16 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
337 |
321 |
$328.81 |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
43 |
37 |
$303.25 |
| 85018 |
|
902 |
876 |
$219.41 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
222 |
136 |
$213.84 |
| 99050 |
|
134 |
127 |
$207.02 |
| 81025 |
|
30 |
30 |
$181.02 |
| 90710 |
|
1,418 |
1,379 |
$157.67 |
| 90633 |
|
1,644 |
1,533 |
$154.73 |
| 90700 |
|
567 |
537 |
$153.28 |
| 99177 |
|
8,362 |
7,848 |
$118.15 |
| 90648 |
|
445 |
442 |
$110.96 |
| J7609 |
Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg |
1,521 |
1,332 |
$104.43 |
| 90680 |
|
2,504 |
2,409 |
$64.82 |
| 90696 |
|
269 |
262 |
$40.50 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
17 |
13 |
$40.03 |
| 36416 |
|
1,246 |
1,170 |
$37.65 |
| 90685 |
|
46 |
46 |
$31.50 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
17 |
13 |
$23.46 |
| 90715 |
|
90 |
90 |
$22.00 |
| 94664 |
|
63 |
63 |
$11.43 |
| 90651 |
|
188 |
186 |
$0.00 |
| 90723 |
|
21 |
21 |
$0.00 |
| 90716 |
|
33 |
33 |
$0.00 |
| 94760 |
|
67 |
63 |
$0.00 |
| 99239 |
Hospital discharge day management, more than 30 minutes |
12 |
12 |
$0.00 |
| H0033 |
Oral medication administration, direct observation |
14 |
14 |
$0.00 |
| 90707 |
|
34 |
34 |
$0.00 |
| 90621 |
|
44 |
44 |
$0.00 |
| 90734 |
|
113 |
112 |
$0.00 |
| 99173 |
|
13 |
13 |
$0.00 |